Peroral Endoscopic Myotomy for the Treatment of Achalasia
ConditionAchalasia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMethodist Health System
About this trial
There will be a retrospective chart review for patients who underwent endoscopic procedures and POEM from 06/2016 - 01/2019 \& a prospective chart review will be performed for patients who will undergo endoscopic procedures and POEM from 02/2019 - 06/2021
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Any discharged patient who has undergone clinically indicated and/or standard of care POEM for the treatment of Achalasia from 6/2016 to 6/2021.
Above or equal to 18 years of age
Disqualifiers
Any patient who has not undergone POEM for the treatment of Achalasia.
Below 18 years of age
Trial population
There will be a retrospective chart review for patients who underwent endoscopic procedures and POEM from 06/2016 - 01/2019. In addition; a prospective chart review will be performed for patients who will undergo endoscopic procedures and POEM from 02/2019 - 06/2021.
Trial design
Design model
Other
Time perspective
Other
Treatments tested in this trial
Endoscopic procedure for achalasia
Procedure/SurgeryPOEM procedure will have a high technical feasibility, with effective clinical resolution of symptoms both in the short and long term.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Decrease or no symptoms of chest pain
To continue and review our treatment outcomes, patient safety in cases with achalasia, we follow up after the procedure up to 180 days. Follow-up period varies from patient to patient.
Time frame
upto 180 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov